Wall Street Zen Downgrades Ennis (NYSE:EBF) to Hold

Key Points

• Wall Street Zen downgraded Ennis (NYSE:EBF) from "buy" to "hold" while Weiss Ratings upgraded the stock to "buy," and MarketBeat's consensus rating remains "Buy."
• Ennis missed quarterly EPS estimates ($0.35 actual vs. $0.38 expected) but beat revenue ($96.36M vs. $95.10M); the shares trade with a market cap of about $514M, a P/E of 12.24, and a 52‑week range of $16.30–$22.36.
• Institutional buying has been notable—Goldman Sachs increased its stake by 34% to 363,680 shares—and roughly 74.33% of Ennis stock is held by institutional investors.

Ennis (NYSE:EBF - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research report issued on Saturday.

Separately, Weiss Ratings raised shares of Ennis from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy".

Ennis Stock Performance

NYSE:EBF opened at $20.32 on Friday. Ennis has a 52 week low of $16.30 and a 52 week high of $22.36. The firm has a market cap of $513.99 million, a price-to-earnings ratio of 12.24 and a beta of 0.31. The firm's 50-day simple moving average is $21.15 and its 200 day simple moving average is $19.13.

Ennis (NYSE:EBF - Get Free Report) last released its quarterly earnings results on Monday, April 20th. The industrial products company reported $0.35 EPS for the quarter, missing analysts' consensus estimates of $0.38 by ($0.03). Ennis had a return on equity of 14.03% and a net margin of 10.86%.The business had revenue of $96.36 million for the quarter, compared to the consensus estimate of $95.10 million.

Hedge Funds Weigh In On Ennis

Several hedge funds have recently bought and sold shares of EBF. Goldman Sachs Group Inc. increased its holdings in Ennis by 34.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 363,680 shares of the industrial products company's stock valued at $7,306,000 after buying an additional 92,266 shares during the period. Empowered Funds LLC bought a new stake in shares of Ennis during the 1st quarter valued at approximately $319,000. Cetera Investment Advisers grew its holdings in shares of Ennis by 4.6% during the 2nd quarter. Cetera Investment Advisers now owns 14,417 shares of the industrial products company's stock valued at $262,000 after purchasing an additional 633 shares during the last quarter. Quantbot Technologies LP grew its holdings in shares of Ennis by 399.6% during the 2nd quarter. Quantbot Technologies LP now owns 4,971 shares of the industrial products company's stock valued at $90,000 after purchasing an additional 3,976 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its holdings in shares of Ennis by 18.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 68,511 shares of the industrial products company's stock valued at $1,243,000 after purchasing an additional 10,744 shares during the last quarter. 74.33% of the stock is owned by institutional investors.

Ennis Company Profile

Ennis, Inc NYSE: EBF is a provider of print and related products and services designed to meet the needs of businesses and organizations across a variety of industries. Headquartered in Dallas, Texas, Ennis offers business forms, checks, manuals, labels, promotional signage and specialty packaging. The company also delivers e-commerce and software solutions that enable customers to manage orders, customize print jobs and streamline supply-chain processes through its integrated online platform.

Ennis's core product offerings include continuous business forms, laser checks and security-enhanced documents, as well as graphic communications materials such as brochures, catalogs and direct-mail collateral.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.